We are pleased the Court agreed to reopen discovery in this litigation. We look forward to the continued deposition of this witness.
New York, New York (PRWEB) May 13, 2013
Transvaginal mesh lawsuits involving products manufactured by C.R. Bard, Inc. continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order issued on May 2nd, the Court has reopened discovery in the proceeding to allow for the deposition of a C.R. Bard executive regarding the alleged use of a prohibited raw polypropylene resin in its mesh products. In doing so, the Court found that the “sheer volume of the production” had prevented plaintiffs from previously discovering emails from the executive that discussed the resin. (In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation “MDL No. 2187”)
“We are pleased the Court agreed to reopen discovery in this litigation. We look forward to the continued deposition of this witness,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the federal C.R. Bard vaginal mesh litigation.
C.R. Bard Vaginal Mesh Lawsuits
Pelvic mesh products manufactured by C.R. Bard and other companies have been the subject of growing litigation since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious vaginal mesh injuries over a three year period. In July 2011, the FDA warned that there had been a five-fold increase in reports of serious complications associated with the use of pelvic mesh in prolapse repair since the 2008 alert. According to the agency, the most frequently-reported injuries include mesh erosion through vaginal tissue, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. There were also reports of bowel, bladder, and blood vessel perforation during insertion, the FDA said. *
According to an Order issued in the Southern District of West Virginia on March 7th, four Bard Avaulta transvaginal mesh lawsuits have been selected for the litigation’s bellwether trials, with the first scheduled to begin on June 11, 2013. Several other vaginal mesh litigations are also underway in West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327. Bernstein Liebhard LLP, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees in these litigations.
In addition to the federal litigations underway in West Virginia, additional transvaginal mesh lawsuits are pending in consolidated proceedings now underway in New Jersey Superior Court, Atlantic County, involving products manufactured by C.R. Bard and Johnson & Johnson’s Ethicon unit. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). Mr. Grand is also serving as Co-Liaison Counsel in both of these litigations. The litigations’ first trial involving a C.R. Bard vaginal mesh lawsuit is scheduled to head to trial in September. However, in March, the jury hearing the proceeding’s first Ethicon mesh trial awarded more than $11 million, including punitive damages, to the Plaintiff. Mr. Grand also served on the trial team in that case. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey)
Victims of alleged vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding transvaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP